Genesis Molecular AI Ser A CVT PFD PP GENESIS THERA SER A CVT PFD STOCK PP

Genesis Molecular AI Ser A CVT PFD PP GENESIS THERA SER A CVT PFD STOCK PP is a security (CUSIP TC08XH789) tracked across SEC portfolio filings. 3 registered fund positions totaling $10.4M via N-PORT as of 2026-03-31.

Summary

Top fund holders (N-PORT)

FundRegistrantValue% of fund
T. Rowe Price New Horizons Fund, Inc.T. ROWE PRICE NEW HORIZONS FUND, INC.$6.0M4.70%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$4.2M3.89%
T. Rowe Price Health Sciences PortfolioT. ROWE PRICE EQUITY SERIES, INC.$191K2.89%

More